financetom
Business
financetom
/
Business
/
US FDA declines to approve Capricor's muscle disorder therapy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA declines to approve Capricor's muscle disorder therapy
Jul 11, 2025 4:13 AM

July 11 (Reuters) - Capricor Therapeutics ( CAPR ) said

on Friday the U.S. Food and Drug Administration has declined to

approve its cell therapy for a type of muscle disorder.

(Reporting by Christy Santhosh in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved